Aimei Health Technology (NASDAQ:AFJK – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.06 EPS for the quarter, Zacks reports.
Aimei Health Technology Stock Performance
Shares of AFJK traded up $0.04 on Tuesday, hitting $11.05. 7,557 shares of the stock traded hands, compared to its average volume of 25,248. Aimei Health Technology has a one year low of $9.60 and a one year high of $41.80. The company has a market capitalization of $67.63 million, a PE ratio of 48.04 and a beta of -0.02. The business has a 50 day simple moving average of $11.67 and a 200 day simple moving average of $11.34.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reissued a “hold (c-)” rating on shares of Aimei Health Technology in a research note on Thursday. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.
Hedge Funds Weigh In On Aimei Health Technology
A hedge fund recently raised its stake in Aimei Health Technology stock. Quarry LP lifted its stake in shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Free Report) by 6.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 167,081 shares of the company’s stock after acquiring an additional 10,000 shares during the quarter. Quarry LP owned approximately 2.73% of Aimei Health Technology worth $1,891,000 at the end of the most recent reporting period. 45.58% of the stock is currently owned by institutional investors.
About Aimei Health Technology
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Recommended Stories
- Five stocks we like better than Aimei Health Technology
- How to Profit From Growth Investing
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
- What Are Dividends? Buy the Best Dividend Stocks
- Amazon Just Did This—and It Didn’t End Well Last Time
- Using the MarketBeat Dividend Yield Calculator
- Stellantis Makes a High-Stakes Bet on Jeep
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
